Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 1
1986 1
1987 1
1990 2
1991 3
1993 2
1994 4
1995 4
1996 4
1997 6
1998 4
1999 8
2000 4
2001 11
2002 7
2003 9
2004 12
2005 18
2006 12
2007 16
2008 7
2009 9
2010 16
2011 14
2012 15
2013 28
2014 35
2015 52
2016 41
2017 35
2018 38
2019 39
2020 35
2021 43
2022 36
2023 33
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

559 results

Results by year

Filters applied: . Clear all
Page 1
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.
Global Cardiovascular Risk Consortium; Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, De Bacquer D, Ballantyne CM, Bernabé-Ortiz A, Bobak M, Brenner H, Carrillo-Larco RM, de Lemos J, Dobson A, Dörr M, Donfrancesco C, Drygas W, Dullaart RP, Engström G, Ferrario MM, Ferrières J, de Gaetano G, Goldbourt U, Gonzalez C, Grassi G, Hodge AM, Hveem K, Iacoviello L, Ikram MK, Irazola V, Jobe M, Jousilahti P, Kaleebu P, Kavousi M, Kee F, Khalili D, Koenig W, Kontsevaya A, Kuulasmaa K, Lackner KJ, Leistner DM, Lind L, Linneberg A, Lorenz T, Lyngbakken MN, Malekzadeh R, Malyutina S, Mathiesen EB, Melander O, Metspalu A, Miranda JJ, Moitry M, Mugisha J, Nalini M, Nambi V, Ninomiya T, Oppermann K, d'Orsi E, Pająk A, Palmieri L, Panagiotakos D, Perianayagam A, Peters A, Poustchi H, Prentice AM, Prescott E, Risérus U, Salomaa V, Sans S, Sakata S, Schöttker B, Schutte AE, Sepanlou SG, Sharma SK, Shaw JE, Simons LA, Söderberg S, Tamosiunas A, Thorand B, Tunstall-Pedoe H, Twerenbold R, Vanuzzo D, Veronesi G, Waibel J, Wannamethee SG, Watanabe M, Wild PS, Yao Y, Zeng Y, Ziegler A, Blankenberg S. Global Cardiovascular Risk Consortium, et al. Among authors: miranda jj. N Engl J Med. 2023 Oct 5;389(14):1273-1285. doi: 10.1056/NEJMoa2206916. Epub 2023 Aug 26. N Engl J Med. 2023. PMID: 37632466 Free PMC article.
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 trial collaborators, et al. Among authors: miranda j. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. Lancet. 2010. PMID: 20554319 Clinical Trial.
All-cause mortality was significantly reduced with tranexamic acid (1463 [14.5%] tranexamic acid group vs 1613 [16.0%] placebo group; relative risk 0.91, 95% CI 0.85-0.97; p=0.0035). The risk of death due to bleeding was significantly reduced (489 [4.9%] vs 574 [5.7%]; rel …
All-cause mortality was significantly reduced with tranexamic acid (1463 [14.5%] tranexamic acid group vs 1613 [16.0%] placebo group; relati …
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag… See abstract for full author list ➔ Bateman RM, et al. Among authors: miranda jp. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Crit Care. 2016. PMID: 27885969 Free PMC article.
Jancik P090 - The SAATELLITE Study: Prevention of S aureus Nosocomial Pneumonia (NP) with MEDI4893, a Human Monoclonal Antibody (mAb) Against S aureus B. Francois, P. F. Laterre, P. Eggimann, A. Torres, M. Sanchez, P. F. Dequin, G. ...J. Capponi, P. …
Jancik P090 - The SAATELLITE Study: Prevention of S aureus Nosocomial Pneumonia (NP) with MEDI4893, a Human Monoclonal Antibody (mAb) Agains …
Effectiveness of cryotherapy on pain intensity, swelling, range of motion, function and recurrence in acute ankle sprain: A systematic review of randomized controlled trials.
Miranda JP, Silva WT, Silva HJ, Mascarenhas RO, Oliveira VC. Miranda JP, et al. Phys Ther Sport. 2021 May;49:243-249. doi: 10.1016/j.ptsp.2021.03.011. Epub 2021 Mar 26. Phys Ther Sport. 2021. PMID: 33813154
Uncertain evidence shows that cryotherapy does not enhance effects of other intervention on swelling (MD = 6.0; 95%CI: 0.5 to 12.5), pain intensity (MD = -0.03; 95%CI: 0.34 to 0.28) and range of motion (p > 0.05). CONCLUSIONS: Current literature lacks evidence supportin …
Uncertain evidence shows that cryotherapy does not enhance effects of other intervention on swelling (MD = 6.0; 95%CI: 0.5 to 12.5), pain in …
Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials.
Araya R, Menezes PR, Claro HG, Brandt LR, Daley KL, Quayle J, Diez-Canseco F, Peters TJ, Vera Cruz D, Toyama M, Aschar S, Hidalgo-Padilla L, Martins H, Cavero V, Rocha T, Scotton G, de Almeida Lopes IF, Begale M, Mohr DC, Miranda JJ. Araya R, et al. Among authors: miranda jj. JAMA. 2021 May 11;325(18):1852-1862. doi: 10.1001/jama.2021.4348. JAMA. 2021. PMID: 33974019 Free PMC article. Clinical Trial.
The proportion of participants in Sao Paulo with a reduction in PHQ-9 score of at least 50% at 3-month follow-up was 40.7% (159/391 participants) in the digital intervention group vs 28.6% (114/399 participants) in the enhanced usual care group (difference, 12.1 percentage points …
The proportion of participants in Sao Paulo with a reduction in PHQ-9 score of at least 50% at 3-month follow-up was 40.7% (159/391 particip …
Biocompatibility of a New Dental Glass Ionomer Cement with Cellulose Microfibers and Cellulose Nanocrystals.
Menezes-Silva R, Pereira FV, Santos MH, Soares JA, Soares SMCS, Miranda JL. Menezes-Silva R, et al. Among authors: miranda jl. Braz Dent J. 2017 Mar-Apr;28(2):172-178. doi: 10.1590/0103-6440201701059. Braz Dent J. 2017. PMID: 28492746 Free article. Portuguese.
At 7 days, Group GIC+NC showed more favorable tissue repair because quantitatively there were more fibroblasts (p=0.022), fewer macrophages (p=0.008) and mononuclear cells (p=0.033). ...At 60 days, test specimens in Group GIC+NC were surrounded by a fibrous t …
At 7 days, Group GIC+NC showed more favorable tissue repair because quantitatively there were more fibroblasts (p=0.022), fewer macro …
Observation of J/psip Resonances Consistent with Pentaquark States in lambda_{b}^{0}J/psiK^{-}p Decays.
Aaij R, Adeva B, Adinolfi M, Affolder A, Ajaltouni Z, Akar S, Albrecht J, Alessio F, Alexander M, Ali S, Alkhazov G, Alvarez Cartelle P, Alves AA, Amato S, Amerio S, Amhis Y, An L, Anderlini L, Anderson J, Andreassi G, Andreotti M, Andrews JE, Appleby RB, Aquines Gutierrez O, Archilli F, d'Argent P, Artamonov A, Artuso M, Aslanides E, Auriemma G, Baalouch M, Bachmann S, Back JJ, Badalov A, Baesso C, Baldini W, Barlow RJ, Barschel C, Barsuk S, Barter W, Batozskaya V, Battista V, Bay A, Beaucourt L, Beddow J, Bedeschi F, Bediaga I, Bel LJ, Bellee V, Belloli N, Belyaev I, Ben-Haim E, Bencivenni G, Benson S, Benton J, Berezhnoy A, Bernet R, Bertolin A, Bettler MO, van Beuzekom M, Bien A, Bifani S, Billoir P, Bird T, Birnkraut A, Bizzeti A, Blake T, Blanc F, Blouw J, Blusk S, Bocci V, Bondar A, Bondar N, Bonivento W, Borghi S, Borsato M, Bowcock TJ, Bowen E, Bozzi C, Braun S, Britsch M, Britton T, Brodzicka J, Brook NH, Bursche A, Buytaert J, Cadeddu S, Calabrese R, Calvi M, Calvo Gomez M, Campana P, Campora Perez D, Capriotti L, Carbone A, Carboni G, Cardinale R, Cardini A, Carniti P, Carson L, Carvalho Akiba K, Casse G, Cassina L, Castillo Garcia L, Cattaneo M, Cauet Ch, Cavallero G,… See abstract for full author list ➔ Aaij R, et al. Among authors: de miranda jm. Phys Rev Lett. 2015 Aug 14;115(7):072001. doi: 10.1103/PhysRevLett.115.072001. Epub 2015 Aug 12. Phys Rev Lett. 2015. PMID: 26317714 Free article.
Observations of exotic structures in the J/psip channel, which we refer to as charmonium-pentaquark states, in lambda_{b}^{0}J/psiK^{-}p decays are presented. The data sample corresponds to an integrated luminosity of 3 fb^{-1} acquired with the LHCb detector from 7 and 8 …
Observations of exotic structures in the J/psip channel, which we refer to as charmonium-pentaquark states, in lambda_{b}^{0}J/psiK^{-}p …
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis.
Bredemeier M, Duarte ÂL, Pinheiro MM, Kahlow BS, Macieira JC, Ranza R, Miranda JR, Valim V, de Castro GR, Bértolo MB, Sauma MF, Fernandes V, Ribeiro AC, Teodoro RB, Brenol CV, Carvalho HM, Studart SA, Pinheiro GR, da Rocha LF Jr, de Lima HD, Pereira IA, Gazzeta MO, Kakehasi AM, Louzada P Jr, Hayata AL, Lupo CM, da Silveira IG, Kowalski SC, Titton DC, Chakr RM, Ranzolin A, Xavier RM, Laurindo IM. Bredemeier M, et al. Among authors: miranda jr. Rheumatology (Oxford). 2024 Feb 1;63(2):456-465. doi: 10.1093/rheumatology/kead232. Rheumatology (Oxford). 2024. PMID: 37216912

Antimalarials were associated with reduced risk of SAEs (mIRR: 0.49; 95% CI: 0.36, 0.68; P < 0.001), total AEs (0.68; 95% CI: 0.56, 0.81; P < 0.001), serious infections (0.53; 95% CI: 0.34, 0.84; P = 0.007) and total hepatic AEs (0.21; 95% CI: 0.05, 0.8

…

Antimalarials were associated with reduced risk of SAEs (mIRR: 0.49; 95% CI: 0.36, 0.68; P < 0.001), total AEs (0.68; 95% CI: 0.56

…
Study of J/ψ Production in Jets.
Aaij R, Adeva B, Adinolfi M, Ajaltouni Z, Akar S, Albrecht J, Alessio F, Alexander M, Ali S, Alkhazov G, Alvarez Cartelle P, Alves AA, Amato S, Amerio S, Amhis Y, An L, Anderlini L, Andreassi G, Andreotti M, Andrews JE, Appleby RB, Archilli F, d'Argent P, Arnau Romeu J, Artamonov A, Artuso M, Aslanides E, Auriemma G, Baalouch M, Babuschkin I, Bachmann S, Back JJ, Badalov A, Baesso C, Baker S, Balagura V, Baldini W, Baranov A, Barlow RJ, Barschel C, Barsuk S, Barter W, Baryshnikov F, Baszczyk M, Batozskaya V, Batsukh B, Battista V, Bay A, Beaucourt L, Beddow J, Bedeschi F, Bediaga I, Beiter A, Bel LJ, Bellee V, Belloli N, Belous K, Belyaev I, Ben-Haim E, Bencivenni G, Benson S, Beranek S, Berezhnoy A, Bernet R, Bertolin A, Betancourt C, Betti F, Bettler MO, van Beuzekom M, Bezshyiko I, Bifani S, Billoir P, Bird T, Birnkraut A, Bitadze A, Bizzeti A, Blake T, Blanc F, Blouw J, Blusk S, Bocci V, Boettcher T, Bondar A, Bondar N, Bonivento W, Bordyuzhin I, Borgheresi A, Borghi S, Borisyak M, Borsato M, Bossu F, Boubdir M, Bowcock TJV, Bowen E, Bozzi C, Braun S, Britsch M, Britton T, Brodzicka J, Buchanan E, Burr C, Bursche A, Buytaert J, Cadeddu S, Calabrese R, Calvi M, Calvo Gomez M, C… See abstract for full author list ➔ Aaij R, et al. Among authors: de miranda jm. Phys Rev Lett. 2017 May 12;118(19):192001. doi: 10.1103/PhysRevLett.118.192001. Epub 2017 May 8. Phys Rev Lett. 2017. PMID: 28548519 Free article.
The fraction of the jet transverse momentum carried by the J/psi meson, z(J/psi)p_{T}(J/psi)/p_{T}(jet), is measured using jets with p_{T}(jet)>20 GeV in the pseudorapidity range 2.5<eta(jet)<4.0. ...However, the results for prompt J/psi production d …
The fraction of the jet transverse momentum carried by the J/psi meson, z(J/psi)p_{T}(J/psi)/p_{T}(jet), is measured using jet …
559 results